Stabilization of thalamo-cortical long-term potentiation by the amygdala: cholinergic and transcription-dependent mechanisms

Eur J Neurosci. 2004 Jul;20(2):557-65. doi: 10.1111/j.1460-9568.2004.03515.x.

Abstract

Synaptic potentiation allows neurons to enhance excitability and store information for extended time periods. We examined the role of the amygdaloid complex, known to facilitate long-term memory encoding, to influence synaptic strength at thalamo-cortical synapses. In urethane-anaesthetized rats, theta-burst stimulation of the dorsal lateral geniculate nucleus of the thalamus induced early phase (1-2 h) long-term potentiation (LTP) of the field postsynaptic potential (fPSP) recorded in the ipsilateral primary visual cortex. Electrical stimulation (100 Hz) of the amygdala 5 min after thalamic stimulation converted early phase LTP to stable late-phase (> 4 h) LTP. This effect was not correlated with the degree of electrocorticographic activation of V1 induced by amygdala stimulation. Amygdala stimulation without thalamic theta-burst stimulation did not change thalamo-cortical fPSPs. The centrally acting cholinergic-muscarinic receptor antagonist scopolamine (1 mg/kg, i.p.), but not peripherally acting methyl-scopolamine, completely blocked the amygdala-induced conversion of early to late-phase thalamo-cortical LTP. Further, ventricular application of the transcription inhibitor anisomycin (250 micro g) reduced amygdala-induced late-phase LTP induction. These results demonstrate that the amygdaloid complex transforms time-limited synaptic enhancement of thalamo-cortical transmission into long lasting increases in synaptic strength. These processes are mediated, at least in part, by cholinergic and transcription-dependent mechanisms. These amygdaloid-induced effects provide a potential mechanism underlying long-term enhancement of sensory transmission and information encoding in thalamo-cortical networks.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amygdala / drug effects
  • Amygdala / physiology*
  • Amygdala / radiation effects
  • Animals
  • Anisomycin / pharmacology
  • Electric Stimulation / methods
  • Excitatory Postsynaptic Potentials / physiology
  • Excitatory Postsynaptic Potentials / radiation effects
  • Functional Laterality
  • Geniculate Bodies / physiology*
  • Geniculate Bodies / radiation effects
  • Long-Term Potentiation / drug effects
  • Long-Term Potentiation / physiology*
  • Long-Term Potentiation / radiation effects
  • Male
  • Muscarinic Antagonists / pharmacology
  • Neural Pathways / drug effects
  • Neural Pathways / physiology
  • Neural Pathways / radiation effects
  • Protein Synthesis Inhibitors / pharmacology
  • Rats
  • Rats, Long-Evans
  • Receptors, Muscarinic / physiology*
  • Scopolamine / pharmacology
  • Synapses / drug effects
  • Synapses / physiology
  • Synapses / radiation effects
  • Time Factors
  • Transcription, Genetic / physiology*
  • Visual Cortex / drug effects
  • Visual Cortex / physiology*
  • Visual Cortex / radiation effects

Substances

  • Muscarinic Antagonists
  • Protein Synthesis Inhibitors
  • Receptors, Muscarinic
  • Anisomycin
  • Scopolamine